BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32324271)

  • 1. Expression and function of the nonclassical estrogen receptor, GPR30, in human cartilage and chondrocytes.
    Ribeiro M; Sousa C; Rufino AT; Judas F; Mendes AF
    J Cell Physiol; 2020 Nov; 235(11):8486-8494. PubMed ID: 32324271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17β-Estradiol on the Expression of G-Protein Coupled Estrogen Receptor (GPER/GPR30) Mitophagy, and the PI3K/Akt Signaling Pathway in ATDC5 Chondrocytes In Vitro.
    Fan DX; Yang XH; Li YN; Guo L
    Med Sci Monit; 2018 Apr; 24():1936-1947. PubMed ID: 29608013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of cell line competence for studies of pharmacological GPR30 modulation.
    Sousa C; Ribeiro M; Rufino AT; Leitão AJ; Mendes AF
    J Recept Signal Transduct Res; 2017 Apr; 37(2):181-188. PubMed ID: 27401115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein coupled estrogen receptor attenuates mechanical stress-mediated apoptosis of chondrocyte in osteoarthritis via suppression of Piezo1.
    Sun Y; Leng P; Guo P; Gao H; Liu Y; Li C; Li Z; Zhang H
    Mol Med; 2021 Aug; 27(1):96. PubMed ID: 34454425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hetero-oligomeric Complex between the G Protein-coupled Estrogen Receptor 1 and the Plasma Membrane Ca2+-ATPase 4b.
    Tran QK; VerMeer M; Burgard MA; Hassan AB; Giles J
    J Biol Chem; 2015 May; 290(21):13293-307. PubMed ID: 25847233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.
    Kang L; Zhang X; Xie Y; Tu Y; Wang D; Liu Z; Wang ZY
    Mol Endocrinol; 2010 Apr; 24(4):709-21. PubMed ID: 20197310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
    Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol and raloxifene induce the proliferation of osteoblasts through G-protein-coupled receptor GPR30.
    Noda-Seino H; Sawada K; Hayakawa J; Ohyagi-Hara C; Mabuchi S; Takahashi K; Nishio Y; Sakata M; Kurachi H; Kimura T
    J Endocrinol Invest; 2013 Jan; 36(1):21-7. PubMed ID: 22453024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.
    Thomas P; Pang Y; Filardo EJ; Dong J
    Endocrinology; 2005 Feb; 146(2):624-32. PubMed ID: 15539556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals.
    Gao F; Ma X; Ostmann AB; Das SK
    Endocrinology; 2011 Apr; 152(4):1434-47. PubMed ID: 21303939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Bakuchiol on chondrocyte proliferation via the PI3K-Akt and ERK1/2 pathways mediated by the estrogen receptor for promotion of the regeneration of knee articular cartilage defects.
    Xu K; Sha Y; Wang S; Chi Q; Liu Y; Wang C; Yang L
    Cell Prolif; 2019 Sep; 52(5):e12666. PubMed ID: 31407423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
    Filardo EJ; Quinn JA; Frackelton AR; Bland KI
    Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol A promoting growth of Sertoli TM4 cells.
    Ge LC; Chen ZJ; Liu HY; Zhang KS; Liu H; Huang HB; Zhang G; Wong CK; Giesy JP; Du J; Wang HS
    Toxicol Lett; 2014 Apr; 226(1):81-9. PubMed ID: 24495410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane.
    Filardo E; Quinn J; Pang Y; Graeber C; Shaw S; Dong J; Thomas P
    Endocrinology; 2007 Jul; 148(7):3236-45. PubMed ID: 17379646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between nuclear and G protein-coupled estrogen receptors.
    Romano SN; Gorelick DA
    Gen Comp Endocrinol; 2018 May; 261():190-197. PubMed ID: 28450143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling.
    Zhou K; Sun P; Zhang Y; You X; Li P; Wang T
    Steroids; 2016 Jul; 111():113-120. PubMed ID: 26850467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of G-Protein Coupled Receptor 30 (GPR30) on Endothelial Inflammation.
    Chakrabarti S; Davidge ST
    Methods Mol Biol; 2016; 1366():503-516. PubMed ID: 26585160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17 beta-estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ER alpha.
    Chimento A; Sirianni R; Delalande C; Silandre D; Bois C; Andò S; Maggiolini M; Carreau S; Pezzi V
    Mol Cell Endocrinol; 2010 May; 320(1-2):136-44. PubMed ID: 20132863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
    Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.